The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Adenotonsillar Hypertrophy, Obstructive Sleep Apnea, Tonsillitis, Adenoiditis

In brief

The investigators aim to investigate the effect of dexmedetomidine on the perioperative respiratory complications in this patient population undergoing both awake and deep tracheal extubation.

Key facts

Study ID

NCT02162433

Run by

Massachusetts Eye and Ear Infirmary

People needed

92

Starts

2015-03-01

Expected to finish

2018-04-23

Last updated by the study team

2020-04-09

Who can join

Age: 3 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients between 3 to 16 years of age undergoing adenotonsillectomy, with or without myringotomy or myringoplasty
• ASA 1 \& 2

You may not qualify if…

• Known allergy or hypersensitivity reaction to dexmedetomidine
• Organ dysfunction (renal/hepatic failure or leukemia)
• Cardiac disease (congenital or acquired)
• Airway or thoracic malformation
• Cerebral palsy
• Hypotonia
• Need for premedication
• Current/recent upper respiratory infection (within four weeks prior to the surgery)
• Asthma
• Allergy or intolerance to clonidine
• Non-English speaking parents/patients.

Where it is running

• MEEI — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.